The role of exercise testing and stress imaging in the management of patients with valvular heart disease (VHD) is reviewed in this article.
R ESUM E
Le rôle de l' epreuve d'effort et de l'imagerie à l'effort dans la prise en charge des patients ayant une cardiopathie valvulaire (CV) est pass e en revue dans cet article. Le American College of Cardiology et la American Heart Associaton ainsi que la Soci et e Europ eenne de Cardiologie et l'Association Europ eenne de Chirurgie Cardio-Thoracique ont r ecemment soulign e le rôle de l' epreuve d'effort pour elucider l' etat symptomatique, et l'utilisation de l'imagerie à l'effort pour evaluer la composante dynamique des anomalies valvulaires et d ecouvrir la dysfonction myocardique sous-clinique qui pourrait ne pas être observ e au repos. De r ecentes etudes ont d emontr e la valeur pronostique diff erentielle de l' echocardiographie à l'effort des patients Transthoracic echocardiography at rest is the preferred method for noninvasive evaluation of valvular heart disease (VHD) because recommendations for surgery are based mainly on the development of symptoms and hemodynamic repercussions on the left ventricle (LV). Nevertheless, the dynamic component of VHD, which is influenced by loading conditions and ventriculo-arterial coupling and subclinical myocardial dysfunction, could be missed at rest. Stress imaging is useful because it addresses clinical responses during exercise testing combined with assessment of the dynamic changes in valvular and ventricular function. Moreover, in patients with low-flow, low-gradient aortic stenosis (AS), dobutamine stress echocardiography (DSE) is recommended to differentiate true severe AS from pseudosevere AS.
1,2 The purpose of this article is to describe the role of exercise testing and stress imaging, mostly echocardiography, in the management of patients with VHD.
Exercise Protocols
Exercise testing is the first choice over pharmacological stress for risk stratification of asymptomatic VHD patients. By decreasing preload and afterload, pharmacological stress with dobutamine has limited utility, except in patients with AS and low LV ejection fraction (LVEF). 3 Safety of exercise testing has been demonstrated and complications remain low, especially in the semisupine position with a lower risk of hemodynamic collapse compared with treadmill. 4, 5 A comprehensive clinical evaluation to rule out the presence of symptoms and to identify potential contraindications is essential before undergoing exercise testing. Contraindications to exercise testing include: clear indications for valve surgery (ie, symptomatic severe AS or mitral stenosis [MS] , uncontrolled hypertension or arrhythmias, physical/mental disability, or systemic disease with the inability to adequately exercise). 6 A symptom-limited exercise test performed under supervision with the goal of reaching at least 85% of the age-predicted heart rate is recommended. Patients should continue taking their usual medication(s), because abnormal exercise testing results while patients are taking suboptimal therapy might be confusing for management decisions.
Exercise stress echocardiography (ESE) in VHD should be performed by an experienced sonographer or cardiologist. Treadmill or semisupine bicycle exercise testing can be performed. Treadmill exercise is more commonly used in North America and is realized according to the American College of Cardiology/American Heart Association (ACC/ AHA) practice guidelines using a modified Bruce protocol. 7 However, this technique allows imaging only after exercise, limiting the accuracy of measurements. In contrast, semisupine ergocycle with a tilting table, which is the preferred approach in Europe, is more physiologic and permits optimal image acquisition during each step of exercise testing. 3 Blood pressure, heart rate, 12-lead electrocardiography, and echocardiographic parameters related to the valve, the LV, and the hemodynamic consequences (eg, pulmonary arterial pressure) are recorded at rest, at each step of the exercise test and during recovery ( Table 1 ). The workload should be adjusted for each patient (ie, beginning at 50 W with an increase of 25 W every 2 minutes for a young patient with preserved LV function vs starting at 25 W with an increase of 10 W every 2 minutes for an older patient with low LVEF). Symptoms should be assessed regularly during the examination. Exercise testing should be interrupted when the target heart rate is reached or if the patient presents typical chest pain, limiting breathlessness, dizziness, hypotension (decrease in systolic blood pressure ! 20 mm Hg), significant ventricular arrhythmia, or muscular exhaustion. The test is considered positive if the patient encounters ! 1 of the following criteria: angina, limiting dyspnea, syncope or nearsyncope, ! 2 mm horizontal or downsloping ST segment depression, decrease or < 20 mm Hg increase in systolic blood pressure, or complex ventricular arrhythmias. 
Aortic Stenosis

Exercise testing
AS is a highly and increasingly prevalent condition which has become a major health concern. 8 Symptomatic status can be difficult to establish, especially in elderly patients, because they might minimize or deny their symptoms or reduce their level of physical activity to avoid them. Exercise testing can be useful to unmask symptoms in patients with severe AS. Approximately one-third of patients who claim to be asymptomatic develop symptoms with exercise testing. 10, 11 For this reason, exercise testing is strongly advocated by the European Society of Cardiology/European Association of Cardiothoracic Surgery (ESC/EACTS) (class I recommendation) 2 whereas the ACC/AHA suggest that it might be considered (class IIa recommendation) in asymptomatic patients with severe AS. 1 However, interpretation of exercise testing could be limited in the elderly population. Positive predictive value in patients > 70 years old has been shown to be significantly lower than in younger patients (56% compared with 79%), with similar negative predictive values. 11 According to this, a negative exercise test in an elderly patient is reassuring, but a positive exercise test might lack in specificity because of frequent comorbidities.
Symptom-limited stress testing, with appropriate supervision and monitoring, has been demonstrated to be safe in severe AS and to add important prognostic value. 12 An exercise test is considered normal if the patient remains asymptomatic (no angina, limiting dyspnea at low workload [ie, during the first steps of exercise], syncope or near-syncope) during the test with an adequate increase in systolic blood pressure (> 20 mm Hg) and absence of complex ventricular arrhythmias. A positive exercise test has been shown to predict the rapid onset of symptoms and cardiac death. 10 Dizziness has the highest positive predictive value for the development of symptoms during the following year. The occurrence of rapidly reversible dyspnea at high workloads should, however, not be interpreted as abnormal. Of note, ST-depression (> 2 mm, horizontal or downsloping) during exercise with AS does not seem to improve the predictive accuracy of the test, particularly in patients with concomitant coronary artery disease (CAD).
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Exercise stress echocardiography Changes in mean aortic gradient. Asymptomatic patients with severe AS and normal LV function undergoing early AVR might have better outcomes than those with medical treatment. 13 However, although AVR is safe and widely performed, the rates of operative mortality and valve-related complications are not null. Therefore, the identification of prognostic factors could help to determine the patients who might benefit the most from early elective surgery. ESE has demonstrated an additive prognostic value over clinical findings, resting echocardiography, and exercise testing. An increase in MTAG by ! 18-20 mm Hg (Fig. 1 ) was associated with an increased risk of cardiac-related events. 14, 15 This increase in MTAG most likely reflects the presence of a more severe AS with a noncompliant, rigid aortic valve (Table 2) . 16 Changes in LV function. Assessment of LV function during exercise also provides incremental prognostic information. Limited contractile reserve (ie, a decrease or a limited increase in LVEF) is associated with an abnormal hemodynamic response to exercise, development of symptoms, and cardiovascular death. 17, 18 Exercise-induced LV dysfunction might represent a more advanced disease state. This could be explained by afterload mismatch and exercise-exhausted coronary flow reserve leading to subendocardial ischemia and more extensive myocardial fibrosis. 25 Standard LVEF measurements are insensitive to detect early forms of LV systolic dysfunction. Assessment of longitudinal LV function seems to be a more powerful parameter in predicting the occurrence of symptoms, exercise intolerance, and outcomes in AS. 26, 27 Longitudinal function can be studied using tissue Doppler imaging with pulsed-wave Doppler at the mitral annulus measuring Sa velocities or using 2-dimensional speckle tracking analyzing global longitudinal strain (GLS). Donal et al. reported that LV contractile reserve assessed with GLS is predominantly altered in patients with an abnormal exercise test (Table 2) . 19 Left ventricular filling pressure estimation and systolic pulmonary artery pressure. Other findings might explain the occurrence of symptoms in patients with severe AS, such as increase of LV filling pressure or systolic pulmonary artery pressure (SPAP) with exercise. At rest, a cutoff value of the ratio of early diastolic mitral inflow velocity to early diastolic annulus velocity (E/Ea) > 13 has been reported to identify an LV end-diastolic pressure > 15 mm Hg with a sensitivity of 93% and a specificity of 88% in moderate-severe AS. 28 Exercise values have yet to be validated in AS patients. Of note, E/Ea ratio should be measured before E and A wave fusion, which appear at high heart rates.
Pulmonary hypertension (PHT) could be unmasked with ESE ( Fig. 1) . In a recent prospective study, exercise-induced PHT, defined as SPAP > 60 mm Hg, was associated with a 2-fold increased risk of cardiac events at 3-year follow-up in asymptomatic patients with severe AS and preserved LVEF (Table 2) . 20 
Impact on clinical decision-making
Current ESC/EACTS and ACC/AHA guidelines recommend AVR in asymptomatic patients with severe AS who present symptoms during exercise testing (ESC/ EACTS, class I; ACC/AHA, class IIa) or a decrease in blood pressure below baseline (ESC/EACTS, class IIa; ACC/AHA, class IIa).
1,2
The ESC/EACTS recently added recommendation for AVR based on ESE, such as the increase of MTAG by > 20 mm Hg during exercise (class IIb). 1,2 This condition is observed in approximately 5%-10% of patients with severe AS and can correspond to 2 different situations: true severe AS with depressed LVEF caused by excessive afterload and concomitant myocardial disease, or pseudosevere AS with myocardial contractile dysfunction leading to reduced valve opening. 29 DSE has been demonstrated to be useful to differentiate true severe from pseudosevere AS and to assess the presence and extent of flow reserve. [30] [31] [32] [33] Flow reserve is calculated as follows: flow reserve (%) ¼ (SV peak e SV rest )/SV rest Â 100 where SV (stroke volume) ¼ 0.785 Â LVOT (left ventricular outflow tract) diameter 2 Â LVOT TVI, respectively, at rest and at peak stress. DSE is a class IIa indication for this purpose according to the current ESC/EACTS and ACC/AHA guidelines. 1, 2 The main objective of DSE is to increase the transvalvular flow rate using a low-dose protocol with gradual increments of dobutamine (5 mg/kg/min) at 5-8 minute intervals to achieve a steady state and avoid tachyarrhythmia or ischemia. 3 The end points for terminating infusion of dobutamine are: (1) heart rate > 220 e age; (2) systolic blood pressure < 80 mm Hg or > 220 mm Hg; (3) ischemia detected using electrocardiogram (> 5 mm flat or downsloping ST depression); (4) complex ventricular arrhythmias or rapid new atrial arrhythmias; (5) breathlessness, angina, dizziness, or syncope; and (6) maximum dose reached (20 mg/kg/min).
34-36
True severe vs pseudosevere AS. True severe AS (Fig. 3) is defined as an increase in MTAG to > 40 mm Hg, a small change in AVA (increase < 0.3 cm 2 ) and/or an AVA 1.0-1.2 cm 2 , and particularly the presence of flow reserve (ie, > 20% increase of stroke volume) with low-dose dobutamine. 2 Presence of both criteria (true AS and presence of flow reserve) will help to identify patients who will benefit the most from AVR in terms of long-term survival and improvement of functional status. 32 Pseudosevere AS is characterized by a significant increase in AVA (increase ! 0.3 cm 2 ) and/or an AVA > 1.2 cm 2 , and an MTAG remaining < 40 mm Hg, explained by the recruitment of LV myocytes leading to greater opening of the "not severely" stenotic aortic valve with low-dose dobutamine. The prevalence of pseudosevere AS is considered to be between 20% and 30% of patients with lowflow, low-gradient AS. 29 These patients should be treated with aggressive heart failure therapy and they might require AVR if medical therapy fails to improve their condition and/or if the stenosis progresses to the severe stage. 37 Figure 1. Doppler findings in an asymptomatic severe aortic stenosis patient at rest (left panels) and at exercise (right panels). A significant increase of MTAG ! 20 mm Hg (A) and exercise-induced PHT (B) are shown, which represent 2 risk factors for cardiac events. AV, aortic valve; AVA, AV area; AV Env. Ti, aortic time interval; HR, heart rate; maxPG, maximal pressure gradient; meanPG, mean pressure gradient; MTAG, mean transaortic gradient; PHT, pulmonary hypertension; TR, tricuspid regurgitation; TTG, transtricuspid gradient; Vmax, maximal velocity; Vmean, mean velocity; VTI, velocity time integral.
Absence of flow reserve. Absence of flow reserve, defined as an increase < 20% of stroke volume using low-dose dobutamine, is present in 30%-40% of patients with a low flow state and could be explained by afterload mismatch (imbalance between AS severity and myocardial reserve), myocardial fibrosis, or concomitant CAD. 29 Patients without flow reserve present much greater operative mortality (22%-32%) during AVR than those with flow reserve (5%-8%). 29, 32, 38 Moreover, lack of flow reserve has been identified as a predictor for surgical and 30-day mortality. 32 Despite high surgical mortality, 5-year mortality was significantly lower after AVR (31%) compared with medical therapy alone (87%) in patients without flow reserve. 38 Also, the lack of flow reserve could not reliably predict the absence of LVEF recovery after surgery because 65% of patients with no flow reserve had a postoperative increase in LVEF of > 10%. 39 According to these data, absence of flow reserve should not be considered an absolute contraindication for AVR. 38, 39 Nevertheless, in patients without flow reserve, stenosis severity often remains indeterminate at the outset of DSE and another imaging modality, such as aortic calcification quantification using computed tomography, might be needed to confirm stenosis severity and indication for surgery. 40, 41 Projected AVA. A limitation of DSE is that the increase in transvalvular flow achieved might vary widely from patient to patient. Hence, interpretation of the AVA and MTAG changes without consideration of the relative change in transvalvular flow might lead to ambiguous results. A way to overcome this limitation is to compare AVA at a standardized mean transvalvular flow rate (Q) of 250 mL/s. This novel parameter, called the projected AVA (AVA proj ), has been shown to be more closely related to actual AS severity and survival than traditional DSE parameters. The AVA proj is calculated as follows: AVA proj ¼ (AVA peak À AVA rest )/ (Q peak À Q rest ) Â (250 À Q rest ) þ AVA rest , where AVA rest and Q rest , and AVA peak and Q peak are AVA calculated by continuity equation and Q by dividing SV (mL) by LV ejection time (s) at rest and at peak DSE, respectively. 34, 35, 42 An AVA proj 1.0 cm 2 is considered to be severe.
Impact on clinical decision-making
In symptomatic patients with low-flow, low-gradient AS and low LVEF, AVR is recommended after the demonstration using DSE of true severe AS with evidence of flow reserve (ESC/EACTS, class IIa; ACC/ AHA, class IIa).
1,2
AVR might also be considered in true severe AS patients without flow reserve after careful evaluation of other comorbidities, particularly CAD (ESC/EACTS, class IIb; ACC/AHA, class IIa).
2
Initial medical therapy with close follow-up is preferred in patients with pseudosevere AS. 37 Surgery could be reconsidered if there is no clinical improvement or if deterioration occurs. The importance of the imbalance between the degree of AS severity and myocardial dysfunction should be regularly assessed and AVR might be considered, arguing that moderate AS could have a similar hemodynamic effect on a failing LV as a severe AS on a preserved LV. In cases of severe myocardial impairment, cardiac transplantation might be considered an option in selected patients (Fig. 2B ). 
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Specific situation of low-flow, low-gradient AS with preserved LVEF
Some patients with severe AS based on calculated AVA might paradoxically present a low-flow, low-gradient condition despite preserved LVEF. This condition, called paradoxical low-flow, low-gradient severe AS, is defined as LVEF ! 50%, stroke volume index 35 mL/m 2 , MTAG < 40 mm Hg, and AVA < 1 cm 2 or < 0.6 cm 2 /m 2 , and could be present in up to 25% of patients with severe AS and preserved LVEF. 43 This pattern seems to represent a more advanced stage of the disease with a reduced 5-year survival compared with patients with normal-flow, high--gradient severe AS (64% vs 82%, respectively). AVR is associated with improved survival compared with medical therapy in these patients. 44 This condition is often misdiagnosed, which leads to the inappropriate delay of surgery. As for patients with low LVEF, low-dose DSE might be useful to unmask pseudosevere AS caused by the lowflow state from true severe AS. Among DSE parameters of AS severity, AVA proj 1 cm 2 seems to have the best accuracy to differentiate true from pseudosevere AS and to predict the risk of adverse cardiac events. 45 Moreover, severe aortic calcification identified using computed tomography might also be helpful to differentiate true vs pseudosevere AS. A threshold of 1651 arbitrary units (AU) or more specifically, 1274 AU for women and 2065 AU for men has been associated with a good sensitivity and specificity (! 80%) for the diagnosis of true severe AS. 40, 41 Some have suggested that vasodilatory stress catheterization using nitroprusside could be used to identify true severe AS in patients with paradoxical low-flow, low-gradient AS. 46 More studies are needed to confirm the usefulness of this approach. Recent ESC/EACTS and ACC/AHA guidelines included a class IIa recommendation (Fig. 2B) for AVR in symptomatic patients with paradoxical low-flow, low-gradient severe AS after careful confirmation of true severe AS.
1,2
Aortic Regurgitation
Exercise testing
The occurrence of symptoms in patients with severe aortic regurgitation (AR) is associated with an excessive mortality rate 47 and represents a strong indication for AVR. 1,2 Exercise testing is reasonable to unmask symptoms and assess functional capacity in patients with severe AR who present equivocal symptoms. Exercise, stress echocardiography, and radionuclide angiography Few studies, including those with small numbers of patients, have evaluated the prognostic value of ESE in AR and, routine clinical use is not recommended. If performed, the main goal should be to unmask subclinical LV dysfunction during exercise using standard LVEF measurement or LV longitudinal function assessment with tissue Doppler imaging or 2-dimensional strain. 48 The demonstration of a limited LV contractile reserve could help to identify patients who might develop progressive LV dysfunction during medical treatment or no improvement in LVEF after AVR. 49 DSE is almost systematically associated with a decrease in AR severity; it might, however, be useful for the assessment of LV contractile reserve or inducible ischemia. In a cohort of 29 patients with severe AR, preoperative exercise-induced change in LVEF measured using radionuclide ventriculography, compared with preoperative LVEF at rest, has been shown as a predictor of postoperative LV performance during exercise. 50 
Impact on clinical decision-making
Although ESE is not recommended for the routine management of AR, measurement of contractile reserve might be useful to unmask subclinical myocardial dysfunction, especially in patients with borderline values of LVEF (50%-55%) or end-systolic diameter (near 50 mm or 25 mm/m 2 ), and might help optimize the timing of surgery. 51 
Mitral Stenosis
Stress echocardiography
The clinical utility of stress imaging for MS is limited to echocardiography. The ACC/AHA and ESC/EACTS guidelines recommend stress echocardiography in patients who present a discrepancy between symptoms and severity of MS at rest: (1) to unmask symptoms in asymptomatic patients with at least moderate MS (< 1.5 cm 2 ), especially in elderly and/or sedentary patients; and (2) to evaluate the hemodynamic effect of exercise in patients with limiting symptoms, but mild MS.
1,2 Stress echocardiography can provide important information regarding exercise-induced symptoms, functional capacity, valve function, and its hemodynamic consequences. Exercise stress, being more physiologic, is preferred. Nevertheless, DSE might also be performed and seems to lead to similar hemodynamic changes in mean transmitral gradient (MTMG) and SPAP. 52 Safety and feasability of DSE have been demonstrated in 53 patients with rheumatic MS. 53 DSE was started at 10 ug/kg/min for 5 minutes and increased by 10 ug/kg/min every 3 minutes to a maximal dose of 40 ug/kg/min. DSE should be performed during usual medical therapy, including b-adrenergic antagonists. 53 Changes in mitral gradient and SPAP. Data regarding the use and prognostic value of stress echocardiography in MS are limited. With DSE in patients with at least moderate MS, the increase of MTMG at peak dose was the best predictor of adverses events (hospitalizations, acute pulmonary edema, or supraventricular arrhytmias) during follow-up (60.5 AE 11 months). A cutoff value of 18 mm Hg allowed the best detection of events (90% sensitivity and 87% specificity). 53 Exercise testing revealed the presence of symptoms in 46% of 48 "asymptomatic" patients with moderate-severe MS. Of interest, MS severity and SPAP at rest were not different between patients who developed dyspnea during exercise compared with truly asymptomatic patients. The magnitude of exercise-induced increase in MTMG and relative SPAP (exercise/rest SPAP) were significantly greater and more rapid in patients with positive exercise testing (Fig. 4) . Also, the cut point of 60 mm Hg for exercise SPAP was not significantly related to the occurence of symptoms, but an early exercise-induced increase in relative SPAP ! 90% at 60 W was associated with a > 2-fold increase in the risk of developping dyspnea or to require mitral valve intervention during follow-up. These observations suggest that the evaluation of changes in MTMG and the pattern of SPAP progression, especially during the first stage of exercise, play an important role in the evaluation of exercise tolerance and underline the benefits of studying hemodynamic changes at every stage of exercise, rather than simply comparing rest and peak exercise values. 54 Atrioventricular compliance. Resting and particularly exercise SPAP could be dramatically different in patients with comparable mitral valve areas but different atrioventricular (AtV) compliance. Patients with low AtV compliance ( 4 mL/mm Hg) represent an important clinical entity in which symptoms correspond to severe increases in SPAP during stress. 55, 56 In a study by Brochet et al., AtV compliance was the only independent predictor, among multiple resting echocardiographic parameters, of exercise dyspnea, and an important determinant of functional impairment. 54 Net AtV compliance can be calculated from the ratio of effective mitral valve area (MVA) (continuity equation) and the E-wave downslope: AtV compliance (mL/mm Hg) ¼ 1270 (MVA [cm 2 ]/E-wave downslope [cm/s]). 55 
Impact on clinical decision-making
When valve anatomy is suitable, percutaneous valvuloplasty may be considered in symptomatic patients with mild MS (MVA > 1.5 cm 2 ) and increase in MTMG > 15 mm Hg with exercise (ACC/AHA, class IIb). 1 In asymptomatic patients with significant MS (MVA < 1.5 cm 2 ), the presence of exercise PHT (SPAP > 60 mm Hg) or increase in MTMG > 15 mm Hg should lead to close follow-up. Because of the greater operative risk and potential longterm complications with a prosthetic valve, stress echocardiography-related indications do not apply to mitral valve replacement (Fig. 5A) .
Primary Mitral Regurgitation
Exercise, stress echocardiography, and radionuclide angiography Primary or organic mitral regurgitation (MR) is a dynamic process. Exercise testing might identify patients with unrecognized symptoms or demystify symptoms that are out of proportion with resting MR severity. Exercise capacity is markedly reduced in approximately 20% of asymptomatic patients with severe MR and is associated with worse outcome, regardless of resting MR severity. 57 ACC/AHA guidelines recommend ESE for asymptomatic severe MR (effective regurgitant orifice area [EROA] ! 40 mm 2 and regurgitant volume [RVol] ! 60 mL) to establish symptom status and exercise tolerance, and for symptomatic patients where there is a discrepancy between symptoms and the severity of MR at rest (class IIa).
1 ESE in a semisupine position should be used to evaluate primary MR. DSE is not useful because of the hemodynamic effects leading to decreases of preload and afterload.
Changes in MR severity, SPAP, and right ventricular function. In chronic asymptomatic moderate-severe primary MR, a marked exercise-induced increase in MR severity (increase of EROA ! 10 mm 2 and RVol ! 15 mL) was found in one-third of patients and > 50% of patients with moderate MR at rest developed severe MR during exercise. The magnitude of this increase was well correlated with exerciseinduced PHT, but unrelated to resting MR severity. 21 Consequently, the main harmful consequence of dynamic MR is the development of exercise-induced PHT. Defined as SPAP > 60 mm Hg with exercise, it was present in 46% of patients and associated with a markedly reduced 2-year symptom-free survival. Moreover, exercise SPAP was a more accurate predictor of progression to symptoms compared with resting SPAP. The best cutoff value of exercise PHT (> 56 mm Hg) was close to that proposed by guidelines (> 60 mm Hg). In contrast, the best cutoff value of SPAP at rest (> 36 mm Hg) was much lower than the value suggested by guidelines (> 50 mm Hg). 22 Kusunose et al. assessed the role of right ventricular (RV) function during exercise using tricuspid annular plane systolic excursion (TAPSE). They showed that exercise TAPSE was a readily available marker and an independent predictor of time to surgery. Patients with concomitant exercise-induced RV dysfunction (TAPSE < 19 mm) and exercise PHT (SPAP > 54 mm Hg) had the worse prognosis. In multivariate analysis, resting LV strain, RV endsystolic area, exercise SPAP, and exercise TAPSE provided the best predictive model of outcome (Table 2) . 23 Similarly, assessment of RV function at exercise using radionuclide cineangiography in asymptomatic patients with normal LV and RV function at rest has been shown to predict subsequent development of surgical indications in patients with a decrease in RV ejection fraction during exercise. 58 Changes in LV function. ESE is useful to unmask subclinical latent LV dysfunction with MR, especially in cases with borderline LVEF (60%-65%) or LV end-systolic diameter (near 40 mm or 22 mm/m 2 ). 4, 59 Absence of contractile reserve, defined as the inability to increase LVEF by > 4% or an end-systolic volume index > 25 cm 3 /m 2 at exercise, has been associated with postoperative LV dysfunction after mitral valve surgery, and progressive deterioration of LV function in medically treated patients. 60 New tools, such as GLS measured using 2-dimensional speckle-tracking at rest and during exercise, can be used to detect limited contractile reserve and predict postoperative LV dysfunction. GLS measured during exercise has been shown to have greater sensitivity and specificity than exercise LVEF in predicting LV dysfunction (LVEF < 50%) after mitral valve surgery. 61 Moreover, the absence of LV contractile reserve using LV GLS (exercise-induced increase < 2%) was significantly associated with higher exercise B-type natriuretic peptide levels and a 2-fold increase in risk of cardiac events. In contrast, there was no significant difference in outcome when LV contractile reserve was assessed using LVEF (Table 2) . 24, 62 Figure 5. Impact of exercise testing and stress echocardiography on clinical decision-making in mitral valve disease: asymptomatic moderate-severe and asymptomatic mild MS (A), and asymptomatic primary severe MR (B). * Patients without criteria for worse prognosis could receive usual follow-up (every 6 months) vs close follow-up (every 3 months). ACC/AHA, American College of Cardiology/American Heart Association; EROA, effective regurgitant orifice area; ESC, European Society of Cardiology; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; MR, mitral regurgitation; MS, mitral stenosis; MTMG, mean transmitral gradient; MVA, mitral valve area; RVol, regurgitant volume; SPAP, systolic pulmonary artery pressure.
Impact on clinical decision-making
In asymptomatic patients with severe primary MR and preserved LVEF, the ESC/EACTS guidelines advocate that surgery is deemed reasonable in patients with SPAP ! 60 mm Hg during exercise (class IIb recommendations).
In the debate opposing "early surgery" vs "watchful waiting," ESE might be relevant for risk stratification and estimation of prognosis. Patients with impaired exercise capacity, marked exercise-induced increase in MR or SPAP (as noted herein) and those without LV contractile reserve represent a subset of high-risk patients in whom "early" surgery could be indicated, particularly in a high-volume surgical centre with excellent rates of durable mitral valve repair success. 4 Conversely, asymptomatic severe MR without any signs of PHT or LV dysfunction during exercise could be safely followedup clinically (Fig. 5B) .
Secondary Mitral Regurgitation
Stress echocardiography
Mitral valve function is intimately related to LV function and is highly dynamic. Transient myocardial ischemia occasionally causes secondary MR. This can be identified using ESE and often implies significant CAD (usually left circumflex or right coronary stenosis). 63 In ischemic or dilated cardiomyopathy, complex LV remodelling, including mitral valve and LV geometry deformation, leads to an imbalance between increased tethering forces and reduced closing forces resulting in significant MR and worse prognosis. 64, 65 ESC/EACTS guidelines emphasize the role of ESE to unmask significant dynamic MR in patients with LV systolic dysfunction. 2 ESE is recommended in patients with LV dysfunction and: (1) exertional dyspnea out of proportion with the resting MR severity or LVEF; (2) acute pulmonary edema without an obvious cause 66 ; (3) moderate MR before surgical revascularization; and (4) for risk stratification of mortality and heart failure. 36 ESE remains the best modality to evaluate the dynamic component of secondary MR, because DSE leads to confounding effects caused by reduction in loading conditions. DSE might, however, be useful to evaluate myocardial viability and/or ischemia when coronary revascularization concomitant with mitral surgery is contemplated.
Changes in MR severity
In patients with chronic secondary MR, an EROA ! 20 mm 2 at rest should be considered severe because of its effect on cardiac mortality. 59 Resting MR severity cannot predict the magnitude of exercise-induced increase of MR. 67 In a cohort of 161 patients with at least mild secondary MR prospectively followed up for 35 AE 11 months, an exercise-induced increase in EROA ! 13 mm 2 predicted mortality and hospitalization for heart failure. 68 Exercise-induced increases in EROA and exercise SPAP (Fig. 6 ) were independently associated with the occurrence of acute pulmonary edema. 66 The prognostic significance of dynamic MR has not been validated in nonischemic cardiomyopathy.
Impact on clinical decision-making
The management of patients with secondary MR is challenging. 69 For moderate-severe secondary MR and LV dysfunction, coronary disease and myocardial viability should be evaluated to consider revascularization options (ACC/AHA class I). 1 Severe secondary MR is not usually improved by revascularization alone and, according to ESC/EACTS and ACC/AHA (class IIa) guidelines, should be addressed during coronary bypass surgery. 1, 2 Management of patients with moderate MR is controversial. The ESC/EACTS guidelines recommend the use of ESE to assess dyspnea, MR severity and SPAP (class IIa). 2 A significant exercise-induced increase of MR (EROA ! 13 mm 2 ) identifies patients at high risk who could possibly benefit from mitral intervention concomitant with surgical revascularization. Conversely, patients with mild-moderate MR with only mild exercise-induced increase in MR might be treated more conservatively. These recommendations need to be validated in a large prospective trial.
Right-Sided Valvular Heart Disease
There are no solid data regarding exercise testing or ESE for prognosis or decision-making in right-sided VHD. Cardiovascular magnetic resonance imaging (CMR) has some applications for VHD. 70 CMR can identify regional 71 or diffuse fibrosis 72 in patients with AS and evaluate viability before revascularization. 73 Stress CMR for evaluating VHD is in its early stages of development and has focused on rightsided VHD, relying on imaging techniques used for detection of CAD. 74 Stress CMR may be performed with either supine ergometer exercise 75, 76 or intravenous inotropes, usually dobutamine using a graded protocol. 77, 78 Ergometer stress CMR is challenging because of motion artifacts.
Pulmonary Stenosis and Regurgitation
Lurz et al. studied 17 patients with significant pulmonary regurgitation (PR) or stenosis who underwent percutaneous pulmonary valve replacement. 76 Patients performed supine ergometer (1-2 W increments per minute) before and 1 month after intervention. Real-time CMR images were obtained at rest and every 3 minutes during exercise to measure end-diastolic, end-systolic, and stroke volumes. The study showed that only after percutaneous pulmonary valve replacement could patients with significant PR or pulmonary stenosis increase total stroke volume with exercise. 76 Roest et al. performed supine ergometer stress CMR at 60% of peak oxygen consumption in 15 patients with corrected Tetralogy of Fallot and PR. 79 They observed an abnormal response of the RV during exercise, suggesting that chronic volume overload from PR might have a deleterious effect on RV function. 79 Valverde et al. performed dobutamine stress CMR in 18 patients with repaired Tetralogy of Fallot and severe PR. 77 They compared pulmonary valve RVol and fraction at rest and at stress using volumetric and phase-contrast flow measurements. The authors caution that RVol and fraction using the 2 methods do not have good agreement, especially during stress, and should not be used interchangeably. 77 Small studies in patients with congenital heart disease indicate that stress CMR is feasible and safe, although it has not yet been shown to influence clinical management. Combination of rest and stress CMR might grow into a comprehensive option for the evaluation of VHD.
Conclusions
Although the strongest recommendations for surgery continue to be based on symptoms and resting LV repercussions, recent studies have confirmed the additive prognostic value of the assessment of exercise-induced symptoms and exercise capacity, and evaluation of the dynamic components of VHD using stress imaging, particularly echocardiography. Stress imaging can be useful to optimize risk stratification and timing of surgery in VHD. Randomized clinical trials are required to confirm that clinical decision-making based on stress imaging for VHD leads to improved outcomes.
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